Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lemonade, Inc. Common Stock (NY:LMND)

64.39 +2.43 (+3.92%)
Streaming Delayed Price Updated: 2:31 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lemonade, Inc. Common Stock

< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
News headline image
2 Stocks That Could Deliver Huge Growth ↗
Find out why Silvergate Capital and Lemonade still have a lot of room to run. 
Via The Motley Fool
News headline image
Is Lemonade Stock Cheap or Expensive Now? ↗
The insurance disruptor has fallen quite a bit, so is it a buy? 
Via The Motley Fool
News headline image
Down Big After Earnings, Is Lemonade a Buy Now? ↗
After reporting its results and a surprising acquisition, the insurance technology company took a dive. 
Via The Motley Fool
News headline image
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ: 
Via Benzinga
News headline image
Why Shares of Lemonade Are Down Today ↗
There is no obvious reason for today's price action. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Stocks That Could Double Your Money by 2023 ↗
These two stocks have the potential to surprise investors next year. 
Via The Motley Fool
News headline image
Prediction: These 2 Stocks Will Soar in 2022 ↗
These two stocks were battered in 2021, but 2022 could be a different story. 
Via The Motley Fool
News headline image
Is Lemonade Stock Going Lower or Did It Bottom? ↗
The stock is down 50% year to date, but the business is doing much better. 
Via The Motley Fool
News headline image
3 Disruptive Tech Stocks That Can Supercharge Your Portfolio ↗
You'll want to get in on this trio that's making waves in their respective industries. 
Via The Motley Fool
News headline image
1 Strong AI-Based Insurance Stock That Isn't Lemonade ↗
This under-the-radar stock is an innovative leader in the insurance space. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Jim Cramer Likes Progyny ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Lemonade, Inc. (NYSE: 
Via Benzinga
News headline image
Here's Why I'm Going to Double Down on Lemonade ↗
The insurance technology company is making serious progress, and the market is overlooking it. 
Via The Motley Fool
News headline image
USAA’s Chief Claims Officer Joins Lemonade
From Lemonade
Via Business Wire
News headline image
These 2 High-Growth Stocks Just Plunged. Are They Still Buys? ↗
Do dropping prices spell disaster or a buying opportunity? 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 ↗
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: 
Via Benzinga
News headline image
2 Disruptive Stocks This Billionaire Is Buying ↗
BlackRock CEO Larry Fink recently bought shares of tech stocks CrowdStrike and Lemonade. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Thinking About Shiba Inu? Buy These 3 Stocks Instead ↗
Here are three high-risk, potentially high-reward businesses to put a little money on. 
Via The Motley Fool
News headline image
7 Short-Squeeze Stocks Loaded With High-Risk, High-Reward Upside ↗
Here are seven of the top short-squeeze stocks investors may want to keep their eye on, as retail investors lay and wait for the next squeeze. 
Via InvestorPlace
News headline image
Is Lemonade Stock a Buy? ↗
The online insurer continues to expand while taking big risks. 
Via The Motley Fool
News headline image
Fintech Focus For November 11, 2021 ↗
Quote To Start The Day: “Sold puts are, quite literally, a bunch of huge buy limit orders below the market, and then a bunch of liquidity-taking stop-losses further down.... 
Via Benzinga
News headline image
Why Lemonade Stock Had a Topsy-Turvy Wednesday ↗
Investors weighed not one, not two, but three analyst price-target cuts following earnings. 
Via The Motley Fool
News headline image
Thinking About Buying Stock In PayPal, Palantir, GE, Lemonade Or CVS? ↗
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in... 
Via Benzinga
News headline image
Lemonade, Inc. (LMND) Q3 2021 Earnings Call Transcript ↗
LMND earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Here's Why the Market Soured on Lemonade Stock Today ↗
The quarterly numbers were better than expected, but some troubling trends and the acquisition of a cash-burning competitor are weighing heavily on investors' minds. 
Via The Motley Fool
News headline image
Is Lemonade Stock a Buy Right Now? ↗
Another good quarter and a surprise acquisition might leave shareholders scratching their heads. 
Via The Motley Fool
News headline image
Lemonade Announces Third Quarter 2021 Financial Results
From Lemonade
Via Business Wire
News headline image
Lemonade To Acquire Metromile
From Lemonade
Via Business Wire
News headline image
What to Expect From Lemonade's Q3 Earnings ↗
Investors should be looking for continued growth across the board. 
Via The Motley Fool
News headline image
Lemonade Is Ripe for Short Squeezing ↗
However, it's going to take a serious jolt to spook short sellers and knock this stock out of its rut. 
Via The Motley Fool
News headline image
Earnings Scheduled For November 8, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.